DOCS (doximity.com) Business Value to Revenue

Public company logo of Doximity Inc (DOCS)

Doximity, Inc. (DOCS) is an authoritative social network for US medical professionals that has become an indispensable tool for professional interaction. A cloud architecture with distributed data storage guarantees the service's stability. High margins and advertising streams ensure excellent scalability. The EV-to-revenue dynamics provided by GURU.Markets data clearly demonstrate the asset's market valuation, where the indicator's current value reaches 7198.65.

DOCS doximity.com: Enterprise Value-to-Revenue Ratio in the range 11/23/2025 - 11/19/2026

Financial and market metric breakdowns for Doximity Network (DOCS)

- price and consensus price forecast:
- business market valuation indicators:
Fundamental company valuation:doximity.com, DOCS
Manufactured product of Doximity Corp

For Doximity, Inc., which monetizes pharmaceutical companies' access to the medical community, this ratio determines the efficiency of revenue generation relative to the total business value. Analyzing the EV/Sales trend, we see the ratio of Enterprise Value to annual sales, which allows for an assessment of the asset regardless of debt load. The current value of 7198.65 serves as an indicator of whether the company is overvalued or undervalued compared to its market potential.

Competitor analysis

Enterprise Value-to-Revenue Multiple veeva.com|HQY: EV/Sales Multiple|Enterprise Value-to-Revenue Multiple Waystar Health (WAY)|Enterprise Value-to-Revenue Ratio CorVel Healthcare|EV/Sales Multiple Privia Medical Group|Company Value to Revenue HURN (Huron Corp)|Company Value to Revenue Certara CERT|EV/Sales Multiple OMCL (Omnicell Inc)|Total Company Value-to-Revenue Ratio GoodRx Inc (GDRX)|Schrodinger Corp - EV/Sales Multiple|Enterprise Value to Sales Volume PHR|OMDA: EV/Sales Multiple|Evolent Health, Inc. - Business Value to Revenue|Enterprise Value-to-Revenue Ratio HealthStream Corp|DH: Business Value to Revenue|Company Value to Revenue CCSI (Consensus)|Total Company Value-to-Revenue Ratio Agilon Health|EV/Sales Multiple ABSI (Absci)|soyoung.com (SY) - Enterprise Value-to-Revenue Multiple|NRC - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio Spok Holdings Inc SPOK|OPRX (OptimizeRx) - Company Value to Revenue|TBRG - Total Company Value-to-Revenue Ratio|Company Value to Revenue SLP|Enterprise Value-to-Revenue Multiple sophiagenetics.com SOPH|EV/Sales Multiple HCAT|CCLD (CareCloud Inc.) - Business Value to Revenue|Enterprise Value-to-Revenue Ratio Research Solutions Inc. RSSS|DLHC - Company Value to Revenue|ONMD - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio Scienture Holdings Inc SCNX|HCTI: EV/Sales Multiple|Company Value to Revenue Ratio ISPC|BFRG (Bullfrog AI) - EV/Sales Multiple|Company Value to Revenue SCWorx Inc (WORX)|EV/Sales Multiple MSPR|ICCT - Enterprise Value-to-Revenue Multiple|EV/Sales Multiple MEDS (TRxADE Health Corp)|Enterprise Value-to-Sales Ratio Orgenesis|R1 RCM - EV/Sales Multiple|Business Value to Revenue SHCR (Sharecare, Inc)|STRM (Streamline Health Solutions Inc.) - Company Value to Revenue|Enterprise Value-to-Revenue Multiple syrahealth.com (SYRA)|Company Value to Revenue AMEH|MODN: Business Value to Revenue|Company Value to Revenue NXGN (NextGen Healthcare)